To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
12 Current news about the topic target validationrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
Lexicon Genetics Incorporated (Nasdaq: LEXG) and Abgenix, Inc. (Nasdaq: ABGX) announced today that Lexicon has delivered to Abgenix, thirteen (13) human antigens for antibody development as part of the companies’ drug discovery alliance. This marks the first of many antigens to be delivered to ...
Athersys Inc. today announced that it has entered into a collaboration with Bristol-Myers Squibb Company (NYSE: BMY) in which Athersys will provide Bristol-Myers Squibb access to its proprietary RAGE-VT™ (Random Activation of Gene Expression for Validated Targets) technology for the ...